Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2016-09-05 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document text is a company announcement (Selskabsmeddelelse nr. 43 dated 5. september 2016) detailing transactions conducted under Novozymes' share buy-back program ('aktietilbagekøbsprogram'). It explicitly lists the number of shares bought, the transaction value, and the specific dates of the trades (August 29 to September 2, 2016). This content directly relates to the company acquiring its own shares, which corresponds precisely to the definition of 'Transaction in Own Shares' (POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), as it focuses solely on capital transactions, not operational or comprehensive financial performance. It is a specific disclosure about share repurchases.
2016-09-05 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a detailed report of Novozymes' stock buyback program, providing specific transaction data (dates, quantities, prices, and execution times) for shares repurchased under the Market Abuse Regulation. It is a recurring disclosure of share repurchases, which falls under the 'Transaction in Own Shares' category. It is not a general regulatory filing or a report publication announcement, as it contains the primary data itself.
2016-09-05 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 90% confidence The document announces that Novozymes has repurchased accumulated shares under its stock buyback program, providing transaction volume and value details. This clearly describes a company buying back its own shares. According to the classification definitions, this falls under Transaction in Own Shares (POS).
2016-09-05 English
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 100% confidence The document text is very short (267 characters) and describes a specific transaction: Novozymes purchased 4,719,307 shares under a previously announced share buyback program (aktietilbagekøbsprogram). This directly relates to the company buying back its own shares. The classification code for this activity is 'POS' (Transaction in Own Shares). Although it mentions reading the full announcement in PDF format, the content itself is the core transaction detail, making POS more specific than RPA or RNS, especially since the text explicitly details the share repurchase activity.
2016-08-29 Danish
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 98% confidence The document is titled 'Transactions under Novozymes' stock buyback program' and provides detailed daily transaction data regarding the company purchasing its own shares (B shares) as part of a previously announced stock buyback program. The key phrases are 'stock buyback program' and the detailed tables showing 'Number of shares' purchased and 'Transaction value'. This directly corresponds to the definition of 'Transaction in Own Shares'.
2016-08-29 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 92% confidence The text describes the company’s repurchase of its own shares under a previously announced stock buyback program, providing specific numbers of shares purchased and transaction value. This clearly falls under the category for reporting transactions in own shares.
2016-08-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.